The miR-4651 demonstrated high accuracy in discriminating individuals with AFB1-positive HCC but AFP-negative from controls (AUC, 0.80; 95% CI, 0.75-0.86) (Figure 6A). The gene discussed is AFP; the disease is hepatocellular carcinoma.